Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database
Mortier, Laurent, Blom, Astrid, van Hille, Benoît, Samimi, Mahtab, Luciani, Laura, Cahuzac, Capucine, Robert, Caroline, Quereux, Gaelle, Maubec, Eve, Miotti, Hakima, Maillard, Cathy, Aubin, François, Lenormand, Cédric, Solbes, Marie-Noëlle, Joly, Pascal, Kachaner, Isabelle, Lebbé, Céleste, Dutriaux, Caroline, Saiag, Philippe
Published in European journal of cancer (1990) (01.09.2024)
Published in European journal of cancer (1990) (01.09.2024)
Get full text
Journal Article
Avelumab as second-line or later (2L+) treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Analysis of real-world outcomes in France using the CARADERM registry and the French national healthcare database
Blom Fily, Astrid, Mortier, Laurent, Kachaner, Isabelle, Meyer, Nicolas, Samimi, Mahtab, Luciani, Laura, Cahuzac, Capucine, Robert, Caroline, Quéreux, Gaëlle, Maubec, Eve, Maillard, Cathy, Miotti, Hakima, Aubin, François, Lenormand, Cédric, Solbes, Marie-Noelle, Joly, Pascal, van Hille, Benoît, Lebbe, Celeste, Dutriaux, Caroline, Saiag, Philippe
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Validité et limites de la base de données Longitudinal Patient Database France pour les études pharmacoépidémiologiques et pharmacoéconomiques
Jouaville, Sophie L., Miotti, Hakima, Coffin, Gabriel, Sarfati, Bruno, Meilhoc, Adeline
Published in Revue d'épidémiologie et de santé publique (01.10.2016)
Published in Revue d'épidémiologie et de santé publique (01.10.2016)
Get full text
Journal Article